SEC EDGARAUG 41 min read$HBAN

Kowalski Kendall A sold $481K of HBAN

Kowalski Kendall A (Chief Information Officer) sold 27,971 shares of HUNTINGTON BANCSHARES INC /MD/ (HBAN) at an average of $17.20 ($17.20–$17.20, $0.48M total) across 2 trades on 2026-08-03.

Original reporting

SEC EDGAR · Kowalski Kendall A

Published Aug 4, 2026, 8:17 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 4, 2026, 8:39 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$HBAN

Neutral

medium confidence

Mentioned

$HBAN

Relevance

4/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$HBANNeutralLow

Why it matters

Traders may monitor insider activity as a sentiment input, but this specific disclosure does not provide new operational or financial information about Huntington Bancshares.

Market read

A fresh insider sale of roughly $481K is disclosed, but there is no accompanying fundamental catalyst in the text.

What to watch

The filing lacks context for why the sale occurred and does not include any offsetting insider buys or other contemporaneous corporate disclosures.

Relevance 4/10Novelty 3/10Timing: Filed on Aug. 4 for Aug. 3 trades, available pre-market/early session depending on broker feed.

Background

The article is an SEC Form 4 insider transaction disclosure for Huntington Bancshares, reporting open-market sales by its Chief Information Officer.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$HBANNeutralMedium confidence

Context

Huntington Bancshares CIO Kendall A Kowalski sold 27,971 shares in open-market transactions totaling about $481K, per a fresh Form 4 filed Aug. 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief unless accompanied by other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction, not guidance, earnings, or a corporate event. The article also notes no 10b5-1 plan, but the text provides no additional context (e.g., tax, diversification, or planned sales schedule) to infer a strong signal.

Market effects

Sector

Minimal. Insider sale in a single bank does not, by itself, reset sector risk or credit expectations.

Regional

Minimal. No regional macro or bank-system stress signal is provided.

Global

Minimal. The disclosure is company-specific and not tied to cross-border events.

Counterpoint

What could challenge this read

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the absence of a 10b5-1 plan does not automatically imply bearish information.

Key entities

issuer
Huntington Bancshares Inc /MD/
Subject of the Form 4 insider transaction disclosure.
insider
Kowalski Kendall A
Chief Information Officer who sold shares in open-market transactions.

Read at source ← All news

OCT 27

$HBANMedAI 8/10

Huntington Bancshares 3Q 2026: Revenue $2.79B, EPS $0.33— 10-Q Summary

Huntington Bancshares reported 3Q 2026 revenue of $2.79B, up 30.8% YoY, and net income of $721M, up 14.6% YoY. EPS was $0.33, down 19.5% YoY, due to acquisition-related expenses. Growth was driven by acquisitions, organic growth, and higher net interest income. Management highlighted progress in integrating recent acquisitions and investing in technology.

tradingview.com1 min

OCT 27

$SEBMed

Sweden’s SEB pauses buybacks as Barclays plans further capital returns ahead of Basel 3.1

SEB paused buybacks due to capital buffer pressure from model adjustments and loan growth, reporting a 17.1% CET1 ratio. Barclays announced a GBP 500M buyback, expecting Basel 3.1 to reduce its CET1 ratio but maintain distribution headroom. EU agreed lower capital requirements for qualifying securitisations. Huntington Bancshares saw diverging capital ratios due to interest-rate losses. BPI's provisions fell despite worsening problem-loan metrics.

theasianbanker.com3 min

OCT 23

$HBANMedAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlights: Strong Fee Growth

Huntington Bancshares (HBAN) reported strong Q3 2026 results, with fee revenue up over 15% YoY and commercial loan growth driving a 1.1% increase in loan balances. The company expects 2027 EPS growth of over 20% and ROTCE of 17%-18%. However, it faces challenges like a competitive environment and slightly lowered fee revenue guidance for Q4. The bank repurchased $460 million in stock YTD and plans $1.8-$1.9 billion in buybacks for 2026-2027.

finance.yahoo.com3 min

OCT 23

$HBANHighAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlig

Huntington Bancshares (HBAN) reported Q3 2026 earnings with net interest income up 0.9% quarter-over-quarter and 37% year-over-year. Net interest margin increased 4 basis points to 3.25%. Non-interest expense remained flat, while value-added fee revenue rose over 15% year-over-year. Loans grew 1.1% period-end, and deposits increased 0.2%. The company expects 2027 EPS growth of over 20% and plans $1.8-$1.9 billion in share repurchases through 2027.

gurufocus.com3 min

OCT 22

$HBANMed

Huntington (HBAN) Q3 2026 Earnings Call Transcript

Huntington (HBAN) reported strong Q3 2026 earnings, with C&I growth driven by national commercial strategy. The company expects 2027 EPS to grow over 20% from 2025, with ROTCE in the 17-18% range. They have completed $460 million in share repurchases year-to-date and plan to return substantial capital to shareholders. Huntington's operating model combines local and national commercial banking, with $191 billion in loans and $225 billion in deposits.